��������

Sourav Kole has been a Member Board of Directors for NeuroTherapia, Inc., Libra Therapeutics, Cerevance, QurAlis, Therini Bio, Inc., and Paros Bio since 2022. Sourav has also been a Director Board of Directors for MindImmune Therapeutics, Inc. and Reservoir Neuroscience since 2022. In addition, since 2022, they have been the Managing Director at Dolby Family Ventures, where they lead the Life Sciences practice focused on neuro investments. Since 2019, they have been the Strategic Partnerships lead at Verily Life Sciences, where they have managed strategic partnerships and joint ventures for next-generation technologies at the convergence of life sciences, data science, and tech with a financial value of $500M+.

Sourav Kole earned a Doctor of Philosophy (Ph.D.) in Biomedical Engineering from the University of Utah. Prior to that, they earned a Bachelor of Science in Biomedical Engineering from Penn State University.